The market expects Eastman Chemical (EMN - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 30. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis specialty chemicals maker is expected to post quarterly earnings of $1.80 per share in its upcoming report, which represents a year-over-year change of +12.5%.
Revenues are expected to be $2.37 billion, up 3.5% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 3.47% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Eastman Chemical?For Eastman Chemical, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.93%.
On the other hand, the stock currently carries a Zacks Rank of #4.
So, this combination makes it difficult to conclusively predict that Eastman Chemical will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Eastman Chemical would post earnings of $1.07 per share when it actually produced earnings of $1.09, delivering a surprise of +1.87%.
Over the last four quarters, the company has beaten consensus EPS estimates just once.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Eastman Chemical doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Shares of Eastman Chemical Company (NYSE:EMN – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are presently covering the company, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $80.50.
EMN has been the subject of several research analyst reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Eastman Chemical in a research report on Monday, May 18th. Royal Bank Of Canada increased their price target on shares of Eastman Chemical from $79.00 to $82.00 and gave the stock a “sector perform” rating in a report on Tuesday, May 5th. Citigroup lowered their price objective on shares of Eastman Chemical from $88.00 to $85.00 and set a “buy” rating on the stock in a research report on Wednesday, June 24th. JPMorgan Chase & Co. lifted their price objective on shares of Eastman Chemical from $80.00 to $82.00 and gave the stock an “overweight” rating in a report on Monday, May 4th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $82.00 target price on shares of Eastman Chemical in a research report on Tuesday, May 5th.
View Our Latest Analysis on Eastman Chemical
Hedge Funds Weigh In On Eastman Chemical Several institutional investors have recently modified their holdings of EMN. MUFG Securities EMEA plc purchased a new stake in Eastman Chemical in the second quarter worth approximately $25,000. Altshuler Shaham Ltd purchased a new position in shares of Eastman Chemical during the fourth quarter worth approximately $25,000. Brown Lisle Cummings Inc. raised its stake in shares of Eastman Chemical by 70.0% during the fourth quarter. Brown Lisle Cummings Inc. now owns 425 shares of the basic materials company’s stock worth $27,000 after acquiring an additional 175 shares in the last quarter. Garton & Associates Financial Advisors LLC bought a new stake in shares of Eastman Chemical in the 4th quarter worth approximately $27,000. Finally, Los Angeles Capital Management LLC purchased a new stake in shares of Eastman Chemical in the 4th quarter valued at $27,000. 83.65% of the stock is currently owned by institutional investors.
Eastman Chemical Trading Up 0.3% Shares of Eastman Chemical stock opened at $69.21 on Thursday. Eastman Chemical has a 12-month low of $56.11 and a 12-month high of $83.47. The company has a current ratio of 1.47, a quick ratio of 0.71 and a debt-to-equity ratio of 0.73. The company has a market cap of $7.91 billion, a price-to-earnings ratio of 20.06, a PEG ratio of 0.89 and a beta of 1.07. The company’s 50-day moving average price is $71.16 and its 200-day moving average price is $72.11.
Eastman Chemical (NYSE:EMN – Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The basic materials company reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.02. The firm had revenue of $2.18 billion during the quarter, compared to analyst estimates of $2.17 billion. Eastman Chemical had a net margin of 4.62% and a return on equity of 8.88%. The business’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same period in the previous year, the business earned $1.91 EPS. Eastman Chemical has set its Q2 2026 guidance at 1.700-1.900 EPS. On average, equities analysts expect that Eastman Chemical will post 6.3 earnings per share for the current fiscal year.
Eastman Chemical Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Wednesday, July 8th. Shareholders of record on Monday, June 15th were paid a dividend of $0.84 per share. The ex-dividend date of this dividend was Monday, June 15th. This represents a $3.36 annualized dividend and a yield of 4.9%. Eastman Chemical’s payout ratio is 97.39%.
Eastman Chemical Company Profile (Get Free Report)
Eastman Chemical Company (NYSE: EMN) is a global specialty materials company that develops, manufactures and markets a broad range of advanced materials, chemicals and fibers. Its product portfolio spans performance additives, functional products, and engineered plastics designed to enhance the durability, appearance and performance of end products across diverse industries.
The company’s main business activities include the production of specialty chemicals used in adhesives, coatings, building materials and consumer care applications, as well as high-performance plastics for packaging, automotive and electronics markets.
Featured Articles Five stocks we like better than Eastman Chemical Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEC.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) Given Average Recommendation of “Moderate Buy” by Analysts
NEXT HEADLINE »Diamondback Energy, Inc. (NASDAQ:FANG) Given Average Rating of “Buy” by Brokerages
SummaryEvery month, we run a screen for dividend growth stocks that could offer some ideas for further due diligence.The screening process considers dividend safety, dividend growth, and dividend growth consistency.REITs tend to show up quite regularly, and that has been particularly notable this month, as we will take a quick dive into three of them.However, we also have a new name showing up this month that looks like an interesting potential turnaround play.This idea was discussed in more depth with members of my private investing community, Cash Builder Opportunities. Learn More » Richard Drury/DigitalVision via Getty Images
Written by Nick Ackerman
For some background on this monthly publication, here is my view on dividend growth stocks:
Dividend growth stocks aren't always the most exciting investments out there. They often aren't grabbing the
5.87K Followers
Analyst’s Disclosure: I/we have a beneficial long position in the shares of VICI, NNN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
A Look at Eastman Chemical Co (EMN) After 3.9% Decline -- GF Value $78.71 vs Price $66.90
On July 08, 2026, Eastman Chemical Co EMN shares fell 3.9% to a current price of $66.90. This decline comes amid a broader trend, with the stock experiencing a 52-week range of $56.11 to $83.47.
GF Value™ verdict: The current price is $66.90, which is 15.0% undervalued compared to the GF Value™ of $78.71.GF Score™: 74/100, indicating an above-average potential for long-term returns.Most notable signal: Insiders sold $0.1M in the last 3 months, with no buying activity. Is EMN Overvalued or Undervalued? Eastman Chemical Co EMN is currently priced at $66.90, which is 15.0% below its GF Value™ of $78.71. This undervaluation suggests a margin of safety for potential investors, as the market price does not fully reflect the company's intrinsic value. The GF Valuation label indicates that EMN is modestly undervalued, presenting an opportunity for value-focused investors who are willing to consider the company's fundamentals.
However, while the undervaluation might be appealing, it is essential to approach with caution. The current economic environment, market volatility, and the company's financial strength must be taken into account. GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates, making it a critical tool for assessing potential investments.
How Does EMN's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 19.4x 13.8x Forward P/E 10.6x N/A The current P/E ratio of 19.4x is significantly above its 5-year median P/E of 13.8x, indicating that the stock is trading at a higher valuation compared to its historical averages. This analysis aligns with the GF Value™ verdict, suggesting that despite the company's current undervaluation, its historical P/E ratios imply a higher valuation than what has been typical for EMN. Thus, while the GF Value™ suggests an opportunity, the elevated P/E indicates a cautionary stance regarding potential overvaluation in the context of historical performance.
What Does EMN's GF Score™ Tell Us? Metric Rating GF Score™ 74 Financial Strength 5/10 Profitability 7/10 Growth 3/10 Valuation 10/10 Momentum 7/10 The GF Score™ of 74/100 reflects a solid overall rating for Eastman Chemical Co, suggesting potential for long-term returns. The strongest area is the Valuation rank, rated at 10/10, indicating that the stock is considered attractive relative to its intrinsic value. However, the Growth rank of 3/10 highlights a weakness in the company's growth prospects, which could be a concern for long-term investors looking for substantial capital appreciation.
What Are Insiders Doing with EMN Stock? In the last three months, insiders at Eastman Chemical Co have sold $0.1 million worth of shares, with no recorded buying activity. This pattern of selling could suggest a lack of confidence among insiders regarding the company's short-term outlook. Insiders typically have a better understanding of the company's operations and future prospects, so their selling activity may warrant caution for potential investors.
What This Means for Investors Based on the GF Value™ assessment, Eastman Chemical Co EMN is currently undervalued. However, the elevated P/E ratio and insider selling activity suggest some caution is warranted. While there may be opportunities for value-oriented investors, the overall picture indicates a need for careful consideration of the associated risks.
For the complete analysis, visit the Eastman Chemical Co EMN stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions What is EMN's GF Score™?
EMN's GF Score™ is 74/100, indicating an above-average potential for long-term returns based on various fundamental factors.
Is EMN overvalued or undervalued?
EMN is currently undervalued, with a GF Value™ of $78.71 compared to the current price of $66.90.
What is EMN's P/E ratio?
EMN's P/E (TTM) is 19.4x, which is significantly higher than its 5-year median P/E of 13.8x, indicating that the stock is trading at a higher valuation than its historical average.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Disclosures I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.
KINGSPORT, Tenn.--(BUSINESS WIRE)--Eastman has scheduled its second-quarter 2026 financial results news release and SEC Form 8-K filing, teleconference and webcast.
Investors looking for stocks in the Chemical - Diversified sector might want to consider either Eastman Chemical (EMN) or Innospec (IOSP). But which of these two stocks presents investors with the better value opportunity right now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.
On top of the Zacks Rank, investors can also look at our innovative Style Scores system to find stocks with specific traits. For example, value investors will want to focus on the "Value" category. Stocks with high Zacks Ranks and "A" grades for Value will be some of the highest-quality value stocks on the market today.
One stock to keep an eye on is Eastman Chemical (EMN - Free Report) . EMN is currently sporting a Zacks Rank #2 (Buy), as well as a Value grade of A. The stock has a Forward P/E ratio of 9.55. This compares to its industry's average Forward P/E of 12.70. Over the past year, EMN's Forward P/E has been as high as 13.09 and as low as 7.66, with a median of 10.44.
Investors should also recognize that EMN has a P/B ratio of 1.27. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. EMN's current P/B looks attractive when compared to its industry's average P/B of 2.06. Within the past 52 weeks, EMN's P/B has been as high as 2.33 and as low as 1.14, with a median of 1.74.
These figures are just a handful of the metrics value investors tend to look at, but they help show that Eastman Chemical is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, EMN feels like a great value stock at the moment.
Eastman Chemical (NYSE: EMN | EMN Price Prediction) is a Kingsport, Tennessee specialty materials company whose molecular recycling (methanolysis) facility is reshaping its cash flow profile. Trading at $72.49 with a 4.56% yield, the question for income investors is straightforward: can the company keep funding the payout through a cyclical chemicals trough?
Dividend Snapshot Metric Value Annual Dividend $3.34 Dividend Yield 4.56% Consecutive Years of Increases 16 years Most Recent Quarterly Rate $0.84 (ex-date June 15, 2026) Dividend Aristocrat Status No (needs 25 years) The Cash Flow Math Works, Even in a Down Year Eastman paid $381 million in dividends in 2025 against $424 million in free cash flow (operating cash flow of $970 million minus capex of $546 million). FY2025 adjusted EPS came in at $5.42, while the dividend run rate is roughly $3.32 per share.
Metric Value Assessment Earnings Payout (Adj.) ~61% Healthy FCF Payout ~90% Elevated OCF Coverage 2.5x Strong The FCF cushion narrowed in 2025 versus $688 million in 2024, but 2026 capex guidance of about $400 million should restore breathing room.
Leverage Is the Real Watch Item Metric Value Net Debt $4.59B EBITDA (TTM) $1.37B Net Debt / EBITDA ~3.4x Cash on Hand (Q1 2026) $665M Leverage above 3x EBITDA is elevated for a cyclical, but the $665 million cash balance and targeted $125 to $150 million in 2026 cost reductions provide insulation.
16 Straight Raises, Including Through 2020 Year Annual Dividend Paid 2025 $381M 2024 $379M 2023 $376M 2022 $381M 2021 $375M The quarterly rate has climbed from $0.46 in 2016 to $0.84 today, and management held the line through the pandemic.
Management Calls Out the Catalyst CEO Mark Costa said on the FY2025 call: “We continued to prioritize stockholder returns and raised the dividend for the 16th consecutive year. In total, we returned approximately $500 million through dividends and share repurchases.” He added: “In 2025, we generated operating cash flow approaching $1 billion, a clear validation of our disciplined approach to cost and working capital management.” The Kingsport methanolysis facility, contributing about $60 million of incremental earnings in 2025 with $30 million more targeted in 2026, is the secular growth engine.
Verdict: Safe, With Leverage as the Asterisk Dividend Safety Rating: Safe. The adjusted-earnings payout near 61% is comfortable, OCF covered the dividend 2.5x, and the recycling ramp adds structural cash flow. EMN screens favorably for income if the methanolysis economics and 11x forward P/E mark a cyclical trough. The risk case builds if olefin pricing weakens further and net debt drifts above $4.59 billion, which would pressure capital allocation. For now, the payout is well covered.
Key Takeaways Eastman acquired Jarylec assets from Arkema, strengthening its dielectric fluids market position.Jarylec products are used in high-voltage transformers and power grid applications.Eastman plans to keep Jarylec production in Marl, Germany, with its quality standards. Eastman Chemical Company (EMN - Free Report) has announced the acquisition of the Jarylec dielectric fluids’ brand and selected assets from Arkema France, strengthening its position as a technology platform and enhancing its offerings in the dielectric fluids market. The acquisition includes key trademarks, customer list, technical documentation and intellectual property associated with the Jarylec brand. The products of this segment are widely used in high-voltage transformers and power grid applications.
Eastman claimed that the customers will continue to receive the quality and service associated with the trusted Jarylec brand, now supported by Eastman’s manufacturing expertise and global technical service network. It plans to continue producing the dielectric fluid products under the Jarylec brand at its existing manufacturing facility in Marl, Germany. The company said it will utilize its state-of-the-art production processes and rigorous quality standards to ensure consistent product performance.
The Jarylec brand has earned a strong reputation in the industry for its reliability and the acquisition is expected to enhance Eastman’s capabilities in serving customers.
Additionally, Eastman expects tailwinds from improved sales volume/mix in Advanced Materials and, to a lesser extent, Additives & Functional Products, along with substantial spread improvement in Chemical Intermediates, in the second fiscal quarter. It has also maintained its cost-reduction target of $125 million to $150 million, net of inflation and expects tailwinds from lower shutdown expense, improved utilization and favorable foreign-currency effects for the next quarter. The capital expenditures are expected to be approximately $400 million in 2026.
EMN shares have lost 3.4% over the past year against the industry’s 8% growth.
Image Source: Zacks Investment Research
EMN’s Zacks Rank & Key PicksEMN currently sports a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Albemarle Corporation (ALB - Free Report) , Dow Inc. (DOW - Free Report) and Avino Silver & Gold Mines Ltd. (ASM - Free Report) .
While ALB and DOW sport a Zacks Rank #1 (Strong Buy) each at present, ASM carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for ALB’s 2026 earnings is pinned at $12.39 per share, indicating a 1,668.35% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 74.5%. ALB’s shares have jumped 177.3% over the past year.
The Zacks Consensus Estimate for DOW’s 2026 earnings is pegged at $2.61 per share, indicating a rise of 377.66% year over year. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters. DOW’sshares have gained 18.1% over the past year.
The Zacks Consensus Estimate for ASM’s current fiscal-year earnings is pinned at 39 cents per share, indicating a 34.48% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 125%.
On May 01, 2026, Eastman Chemical Co (EMN) shares rose 6.1%, closing at $77.53. The stock has been on a positive trajectory recently, with a 1-week increase of
Eastman Chemical remains a 'Buy,' benefiting from Middle East supply disruptions that are tightening markets and supporting price increases, especially in Chemical Intermediates. EMN expects Q2 EPS of $1.70–$1.90 and full-year EPS above $6, with free cash flow supporting a 4.3% dividend yield and $150 million in buybacks. Segment performance is mixed: Advanced Materials faces margin pressure, Additives & Functional sees stable growth, while Fibers is hit by tariffs and Middle East exposure.
KINGSPORT, Tenn.--(BUSINESS WIRE)--The Board of Directors of Eastman Chemical Company (NYSE:EMN) has declared a quarterly cash dividend of $0.84 per share on the company's common stock.
Eastman Chemical CEO Mark Costa discusses the impact of the Middle East conflict on global petrochemical markets and the plastic supply chain on ‘The Claman Countdown.' #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #theclamancountdown #iran #war #middleeast #conflict #global #petrochemical #plastics #plastic #supplychain #markets #oil #energy #business #economy #ceo #eastmanchemical #markcosta
EMN Responds to Market with Solid Economics, Increased Recoveries, and New Commercial Plant Optionality Vancouver, British Columbia--(Newsfile Corp. - May 14, 2026) - Euro Manganese Inc. (TSXV: EMN) (ASX: EMN) (FSE: E060) and its subsidiary Mangan Chvaletice, s.r.o. ("Mangan" and together the "Company", "Euro Manganese" or "EMN") is pleased to announce the results of a new Preliminary Economic Assessment ("PEA") for the development of its Chvaletice Manganese Project ("Chvaletice Manganese Project", "CMP", or "Project") in the Czech Republic.
KINGSPORT, Tenn.--(BUSINESS WIRE)--Eastman announced that its Kingsport, Tennessee, site has achieved ISO 59014 certification through SCS Global Services.
Key permitting secured for Chvaletice Manganese Project continues to de-risk the pathway to production. Vancouver, British Columbia--(Newsfile Corp. - May 27, 2026) - Euro Manganese Inc. (TSXV: EMN) (ASX: EMN) (FSE: E06) is pleased to provide a progress update on the permitting process for the Chvaletice Manganese Project (the "Project") by its wholly-owned subsidiary MANGAN Chvaletice, s.r.o.
KINGSPORT, Tenn.--(BUSINESS WIRE)--Eastman Board Chair and CEO Mark Costa will address the Deutsche Bank 17th Annual Basic Materials Conference on June 3, 2026, at 9:25 a.m. ET.
Eastman Chemical Company (NYSE: EMN): Basic Materials Conference Mark Costa, Board Chair and Chief Executive Officer, Eastman Chemical Company (NYSE: EMN
Abel deployed tens of billions of dollars in capital last quarter across multiple investments. These three large purchases have all produced very positive results for Berkshire so far.
